Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
UCLA Clinical Genomics Center, |
RCV000198805 | SCV000255357 | likely pathogenic | Charcot-Marie-Tooth disease axonal type 2Q | 2013-05-07 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000579104 | SCV000681058 | uncertain significance | not provided | 2019-10-07 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 25326637, 29669943) |
Labcorp Genetics |
RCV002515470 | SCV003290210 | pathogenic | 2-aminoadipic 2-oxoadipic aciduria | 2022-05-31 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg834*) in the DHTKD1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DHTKD1 are known to be pathogenic (PMID: 23141293, 25860818). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 216917). This premature translational stop signal has been observed in individual(s) with clinical features of Charcot-Marie-Tooth disease and/or eosinophilic esophagitis (PMID: 25326637, 29669943). This variant is present in population databases (no rsID available, gnomAD 0.006%). |
Molecular Genetics Lab, |
RCV003883140 | SCV004697625 | likely pathogenic | 2-aminoadipic 2-oxoadipic aciduria; Charcot-Marie-Tooth disease axonal type 2Q | criteria provided, single submitter | clinical testing |